Health and Healthcare

Amgen : AMGN

All Amgen Articles

707 Articles

Chris Lange | Apr 22, 2018 at 10:15 AM EDT

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and…

Jon C. Ogg | Apr 17, 2018 at 11:35 AM EDT

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S.…

Chris Lange | Apr 11, 2018 at 9:05 AM EDT

Short Sellers Back Way Off Major Biotechs

The March 29 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Mar 27, 2018 at 9:30 AM EDT

Major Biotechs See Rising Tide in Short Interest

The March 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Mar 17, 2018 at 7:55 AM EDT

Even More Biopharma Catalysts Coming Through the End of March

Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates…

Chris Lange | Mar 12, 2018 at 9:45 AM EDT

Major Biotechs: Tough Call for Short Sellers

The February 28 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Mar 3, 2018 at 8:40 AM EST

Major Biopharma Catalysts and FDA Events to Look For in March

24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in…

Chris Lange | Feb 28, 2018 at 9:15 AM EST

Major Biotechs Continue to See a Rising Tide of Short Interest

The short interest data are out for the most recent settlement date, February 15. Generally speaking, companies within the biotech…

Lee Jackson | Feb 28, 2018 at 8:40 AM EST

Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings

These five stocks come with upward earnings revisions and the potential for rising dividends. They all make good sense for…

Lee Jackson | Feb 14, 2018 at 8:10 AM EST

Top Analyst Has 3 Large Cap Biotechs to Buy as Massive Selling Subsides

With indiscriminate selling absolutely punishing some of the top large cap biotech stocks, one analyst says now is the time…

Chris Lange | Feb 12, 2018 at 9:15 AM EST

Major Biotechs See Rising Tide of Short Interest

The January 31 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Feb 5, 2018 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Boeing, Chevron, Exxon, Foot Locker, Lowe’s, Nokia, PayPal, Sprint, Wells Fargo and More

The top analyst upgrades, downgrades and other research calls from Monday include Amgen, Boeing, Chevron, Exxon Mobil, Foot Locker, Lowe's,…

Jon C. Ogg | Feb 2, 2018 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Alibaba, Alphabet, Amazon, Amgen, Apple, Mastercard, Nokia, Shopify, US Steel and More

The top analyst upgrades, downgrades and other research calls from Friday include Alibaba, Alphabet, Amazon, Amgen, Apple, Mastercard, Nokia, Shopify…

Chris Lange | Jan 25, 2018 at 10:05 AM EST

Short Sellers Raise the Stakes in Major Biotechs

The January 12 short interest data have been compared with the previous report, and short interest moves in the selected…

Jon C. Ogg | Jan 23, 2018 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Caterpillar, Dollar General, Duke Energy, GE, Honeywell, 3M, Netflix, Sprint and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Amgen, Caterpillar, Dollar General, Duke Energy, General Electric,…

1 … 16 17 18 19 20 … 48

Amgen : AMGN

All Amgen Articles

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Short Sellers Back Way Off Major Biotechs

Major Biotechs See Rising Tide in Short Interest

Even More Biopharma Catalysts Coming Through the End of March

Major Biotechs: Tough Call for Short Sellers

Major Biopharma Catalysts and FDA Events to Look For in March

Major Biotechs Continue to See a Rising Tide of Short Interest

Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings

Top Analyst Has 3 Large Cap Biotechs to Buy as Massive Selling Subsides

Major Biotechs See Rising Tide of Short Interest

Top Analyst Upgrades and Downgrades: Amgen, Boeing, Chevron, Exxon, Foot Locker, Lowe’s, Nokia, PayPal, Sprint, Wells Fargo and More

Top Analyst Upgrades and Downgrades: Alibaba, Alphabet, Amazon, Amgen, Apple, Mastercard, Nokia, Shopify, US Steel and More

Short Sellers Raise the Stakes in Major Biotechs

Top Analyst Upgrades and Downgrades: Amgen, Caterpillar, Dollar General, Duke Energy, GE, Honeywell, 3M, Netflix, Sprint and More

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

The CLARITY Act Is Now One Clause Away From Passing: Should XRP Holders Celebrate?

“If You Own Too Much Tech, You’re Going To Be Slaughtered.” Cramer Urges Investors To Take Profits

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

They Retired to a Rural Town on a Fixed Social Security Income. Then Their County Became a Pharmacy Desert.

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

The CLARITY Act Is Now One Clause Away From Passing: Should XRP Holders Celebrate?

Amgen : AMGN

All Amgen Articles

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Short Sellers Back Way Off Major Biotechs

Major Biotechs See Rising Tide in Short Interest

Even More Biopharma Catalysts Coming Through the End of March

Major Biotechs: Tough Call for Short Sellers

Major Biopharma Catalysts and FDA Events to Look For in March

Major Biotechs Continue to See a Rising Tide of Short Interest

Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings

Top Analyst Has 3 Large Cap Biotechs to Buy as Massive Selling Subsides

Major Biotechs See Rising Tide of Short Interest

Top Analyst Upgrades and Downgrades: Amgen, Boeing, Chevron, Exxon, Foot Locker, Lowe’s, Nokia, PayPal, Sprint, Wells Fargo and More

Top Analyst Upgrades and Downgrades: Alibaba, Alphabet, Amazon, Amgen, Apple, Mastercard, Nokia, Shopify, US Steel and More

Short Sellers Raise the Stakes in Major Biotechs

Top Analyst Upgrades and Downgrades: Amgen, Caterpillar, Dollar General, Duke Energy, GE, Honeywell, 3M, Netflix, Sprint and More

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

The CLARITY Act Is Now One Clause Away From Passing: Should XRP Holders Celebrate?

“If You Own Too Much Tech, You’re Going To Be Slaughtered.” Cramer Urges Investors To Take Profits

Featured Reads

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

They Retired to a Rural Town on a Fixed Social Security Income. Then Their County Became a Pharmacy Desert.